Seeing Is Believing

Currently out of the existing stock ratings of Eun Yang, 128 are a BUY (79.5%), 28 are a HOLD (17.39%), 5 are a SELL (3.11%).
Analyst Eun Yang, carries an average stock price target met ratio of 55.52% that have a potential upside of 37.03% achieved within 327 days. Previously, Eun Yang worked at JEFFERIES.
Eun Yang’s has documented 324 price targets and ratings displayed on 43 stocks. The coverage was on Healthcare, Basic Materials, Technology, Energy sectors.
Most recent stock forecast was given on RIGL, Rigel Pharmaceuticals at 05-Nov-2025.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for RIGL (RIGEL PHARMACEUTICALS) at 6/8/2022. The price target of $10 was fulfilled within 9 days with a profit of $2.99 (42.65%) receiving and performance score of 47.39.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Feb-2023
$42
$-2.15 (-4.87%)
$42
3 years 7 months 16 days ago
(15-Feb-2023)
0/16 (0%)
$-2.18 (-4.93%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$82
3 years 8 months 20 days ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$42
$-2.15 (-4.87%)
$68
3 years 8 months 20 days ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold Since 11-Jan-2023
$55
3 years 8 months 20 days ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Buy Since 09-Jan-2023
$42
$-2.15 (-4.87%)
$61
3 years 8 months 22 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)